JW Pharmaceutical Corporation (KRX:001060)
32,100
-400 (-1.23%)
Apr 29, 2026, 3:30 PM KST
JW Pharmaceutical Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 39,233 | 10,430 | 15,909 | 33,898 | 33,366 | Upgrade
|
| Short-Term Investments | 10,108 | 22,121 | 48,288 | 53,781 | 32,300 | Upgrade
|
| Trading Asset Securities | 12,000 | - | 30,000 | 62,000 | - | Upgrade
|
| Cash & Short-Term Investments | 61,341 | 32,551 | 94,196 | 149,678 | 65,666 | Upgrade
|
| Cash Growth | 88.45% | -65.44% | -37.07% | 127.94% | 18.76% | Upgrade
|
| Accounts Receivable | 114,573 | 135,503 | 159,378 | 147,523 | 151,780 | Upgrade
|
| Other Receivables | 3,581 | 3,571 | 5,644 | 5,962 | 5,499 | Upgrade
|
| Receivables | 118,154 | 155,763 | 173,521 | 156,362 | 187,379 | Upgrade
|
| Inventory | 109,897 | 111,733 | 106,091 | 111,668 | 102,528 | Upgrade
|
| Prepaid Expenses | 2,216 | 1,883 | 1,848 | 1,774 | 5,152 | Upgrade
|
| Other Current Assets | 4,904 | 4,484 | 2,434 | 5,975 | 5,727 | Upgrade
|
| Total Current Assets | 296,512 | 306,413 | 378,091 | 425,457 | 366,452 | Upgrade
|
| Property, Plant & Equipment | 165,279 | 172,291 | 155,724 | 123,048 | 118,392 | Upgrade
|
| Long-Term Investments | 33,240 | 63,801 | 36,995 | 33,957 | 98,884 | Upgrade
|
| Goodwill | - | - | 1,404 | - | - | Upgrade
|
| Other Intangible Assets | 12,877 | 10,878 | 12,248 | 11,750 | 12,773 | Upgrade
|
| Long-Term Deferred Tax Assets | 20,363 | 13,569 | 20,623 | 21,811 | 20,802 | Upgrade
|
| Long-Term Deferred Charges | 51,581 | 29,958 | 16,704 | 4,516 | 8,700 | Upgrade
|
| Other Long-Term Assets | 9,144 | 7,688 | 7,746 | 269.55 | 4,050 | Upgrade
|
| Total Assets | 605,273 | 604,599 | 645,039 | 627,973 | 633,053 | Upgrade
|
| Accounts Payable | 55,864 | 59,613 | 73,847 | 82,908 | 51,643 | Upgrade
|
| Accrued Expenses | 32,842 | 22,204 | 14,495 | 12,472 | 10,343 | Upgrade
|
| Short-Term Debt | 20,000 | 31,400 | 72,968 | 46,000 | 81,823 | Upgrade
|
| Current Portion of Long-Term Debt | 12,102 | 10,000 | 40,166 | 160,440 | 39,977 | Upgrade
|
| Current Portion of Leases | 4,079 | 4,352 | 4,270 | 1,253 | 1,274 | Upgrade
|
| Current Income Taxes Payable | 12,964 | 7,794 | 11,114 | 10,153 | 24,877 | Upgrade
|
| Current Unearned Revenue | 174.55 | 159.58 | 159.58 | 153.65 | 551.41 | Upgrade
|
| Other Current Liabilities | 71,133 | 73,092 | 69,907 | 66,752 | 72,188 | Upgrade
|
| Total Current Liabilities | 209,159 | 208,615 | 286,927 | 380,131 | 282,678 | Upgrade
|
| Long-Term Debt | - | 25,102 | 30,000 | - | 120,744 | Upgrade
|
| Long-Term Leases | 18,454 | 20,872 | 22,876 | 1,849 | 1,326 | Upgrade
|
| Long-Term Unearned Revenue | 997.4 | 1,157 | 1,317 | - | - | Upgrade
|
| Pension & Post-Retirement Benefits | 1,080 | 5,892 | 10,321 | 7,314 | 22,402 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 1,106 | 1,166 | 1,276 | 1,399 | - | Upgrade
|
| Other Long-Term Liabilities | 5,108 | 12,309 | 26,882 | 11,520 | 17,364 | Upgrade
|
| Total Liabilities | 235,904 | 275,112 | 379,598 | 402,214 | 444,514 | Upgrade
|
| Common Stock | 62,253 | 62,253 | 61,100 | 59,418 | 57,202 | Upgrade
|
| Additional Paid-In Capital | 68,321 | 68,321 | 69,475 | 71,063 | 63,334 | Upgrade
|
| Retained Earnings | 214,569 | 164,123 | 113,029 | 89,130 | 58,595 | Upgrade
|
| Treasury Stock | -21,616 | -12,076 | -11,325 | -11,065 | -10,783 | Upgrade
|
| Comprehensive Income & Other | 45,842 | 46,865 | 33,162 | 31,808 | 32,847 | Upgrade
|
| Total Common Equity | 369,370 | 329,487 | 265,440 | 240,354 | 201,195 | Upgrade
|
| Minority Interest | 0 | 0 | 0 | -14,595 | -12,655 | Upgrade
|
| Shareholders' Equity | 369,370 | 329,487 | 265,440 | 225,759 | 188,540 | Upgrade
|
| Total Liabilities & Equity | 605,273 | 604,599 | 645,039 | 627,973 | 633,053 | Upgrade
|
| Total Debt | 54,635 | 91,726 | 170,280 | 209,542 | 245,145 | Upgrade
|
| Net Cash (Debt) | 6,706 | -59,175 | -76,084 | -59,864 | -179,479 | Upgrade
|
| Net Cash Per Share | 276.26 | -2405.58 | -3196.37 | -2577.51 | -7733.47 | Upgrade
|
| Filing Date Shares Outstanding | 27.99 | 22.97 | 22.54 | 22.34 | 22.35 | Upgrade
|
| Total Common Shares Outstanding | 27.99 | 23.31 | 23.33 | 23.34 | 23.21 | Upgrade
|
| Working Capital | 87,353 | 97,798 | 91,164 | 45,326 | 83,774 | Upgrade
|
| Book Value Per Share | 13194.16 | 14136.82 | 11375.92 | 10299.98 | 8669.19 | Upgrade
|
| Tangible Book Value | 356,493 | 318,608 | 251,788 | 228,604 | 188,422 | Upgrade
|
| Tangible Book Value Per Share | 12734.20 | 13670.08 | 10790.83 | 9796.44 | 8118.81 | Upgrade
|
| Land | 44,536 | 44,536 | 26,555 | 22,178 | 22,178 | Upgrade
|
| Buildings | 120,753 | 120,046 | 112,052 | 110,929 | 110,161 | Upgrade
|
| Machinery | 163,999 | 173,804 | 169,111 | 158,179 | 151,192 | Upgrade
|
| Construction In Progress | 3,128 | 3,588 | 6,064 | 8,128 | 849.45 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.